読み込み中
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
通常取引
$27.97
+$0.04 · +0.14%
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
77
割安
センチメント
60
まちまち
リスク
25
中程度のリスク
モメンタム
67
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
日中レンジ
現在 $27.97
52週レンジ
現在 $27.97
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 12.89億 USD | 11.67億 USD | 10.89億 USD | 7.87億 USD | 5.01億 USD |
| 売上原価 | 9.84億 USD | 9.14億 USD | 8.5億 USD | 6.2億 USD | 3.88億 USD |
| 粗利益 | 3.04億 USD | 2.53億 USD | 2.39億 USD | 1.67億 USD | 1.12億 USD |
| 販売・一般管理 | 2.19億 USD | 1.86億 USD | 1.77億 USD | 1.44億 USD | 7979.5万 USD |
| 営業費用 | 2.19億 USD | 1.86億 USD | 1.77億 USD | 1.44億 USD | 7979.5万 USD |
| 受取利息 | 1015.5万 USD | 1574.7万 USD | 850.7万 USD | 81.4万 USD | 46.1万 USD |
| 減価償却費と償却費 | 494.8万 USD | 317.5万 USD | 228.1万 USD | 160.1万 USD | 130.1万 USD |
| 営業利益 | 8527.7万 USD | 6745.5万 USD | 6218.4万 USD | 2334.1万 USD | 3234万 USD |
| 純利益 | 5852万 USD | 5433.6万 USD | 6203.7万 USD | 3035.8万 USD | 6576.9万 USD |
会社概要が更新されました 2026年10月12日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
